Bimodal effects on lipid droplets induced in cancer and non-cancer cells by chemotherapy drugs as revealed by green-emitting BODIPY fluorescent probe

Artūras Polita,Rokas Žvirblis,Jelena Dodonova-Vaitkuniene,Arun Prabha Shivabalan,Karolina Maleckaite,Gintaras Valinčius
DOI: https://doi.org/10.1039/d3tb02979d
IF: 7.571
2024-02-21
Journal of Materials Chemistry B
Abstract:Lipid droplets (LDs) are cytoplasmic lipid-rich organelles with important roles in lipid storage and metabolism, cell signaling and membrane biosynthesis. Additionally, multiple diseases, such as obesity, fatty liver, cardiovascular diseases and cancer, are related to the metabolic disordered of LDs. In various cancer cells, LD accumulation is associated with resistance to cell death, reduced effectiveness of chemotherapeutic drugs, increased proliferation and aggressiveness. In this work, we present a new viscosity-sensitive, green-emitting BODIPY probe capable of distinguishing between ordered and disordered lipid phases and selectively internalising into LDs of live cells. Through the use of fluorescence lifetime imaging microscopy (FLIM), we demonstrate that LDs in live cancer (A549) and non-cancer (HEK 293T) cells have vastly different microviscosities. Additionally, we quantify the microviscosity changes in LDs under the influence of the DNA-damaging chemotherapy drugs doxorubicin and etoposide. Finally, we show that doxorubicin and etoposide have different effects on the microviscosities of LDs in chemotherapy-resistant A549 cancer cells.
materials science, biomaterials
What problem does this paper attempt to address?